Returning investor GV returned for a round which hiked the clinical data software provider's overall funding to over $470m.

DNAnexus, a US-based provider of biomedical data analysis software, raised $200m in funding from investors including GV, a corporate venturing subsidiary of internet and technology conglomerate Alphabet, yesterday.

Alternative investment firm Blackstone’s Growth fund led the round, which also featured Perceptive Advisors, Innovatus Capital Partners, Foresite Capital and Northpond Ventures.

Founded in 2009, DNAnexus operates a cloud-based platform enabling clinical researchers to stores, share, analyse and manage complex clinical data. It claims the platform contains 65 petabytes of data has…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Fernando Moncada Rivera

Fernando Moncada Rivera is a reporter at Global Corporate Venturing and also host of the CVC Unplugged podcast.
Email LinkedIn